Welcome to our dedicated page for Newtopia news (Ticker: NEWUF), a resource for investors and traders seeking the latest updates and insights on Newtopia stock.
Newtopia Inc. reports developments tied to its tech-enabled whole health and habit change platform for chronic and metabolic disease prevention. The company uses genetic, social and behavioral insights, virtual care, digital tools, connected devices and data science to build individualized programs for employers, health plans and other benefit sponsors.
Recurring news themes include employer and health-plan partnerships, community health collaborations, program outcomes for weight, A1C and engagement, and GLP-1 companion offerings such as GLP-1 Ally and GLP-1 Sustain. Company updates also cover financing actions, credit facilities and corporate-status matters for its Canadian-listed shares and U.S. OTCQB quotation under NEWUF.
Newtopia Inc. (TSXV: NEWU) announced the transition of its Chief Financial Officer. Effective June 25, 2021, Edmond Lem will reassume the role of interim CFO, previously held before Anthony Lam's appointment in November 2020. Lem brings over 25 years of experience and has been pivotal in Newtopia's public listing. The company also released an updated investor presentation detailing a trial's results conducted with a Fortune 50 financial services firm, focusing on client outcomes during COVID-19.
Newtopia Inc. plans to announce its financial results for Q1 2021 after market close on May 20, 2021. The earnings release, along with audited annual financial statements and a Management Discussion & Analysis, will be made available on its Investor Relations page. Newtopia focuses on providing tech-enabled habit change solutions to prevent chronic diseases, leveraging insights to create personalized prevention programs aimed at improving health outcomes for type 2 diabetes, heart disease, and more.
Newtopia Inc. (TSXV: NEWU) announced its entry into the Canadian market via a partnership with Eastern Health and Medtronic to implement a type 2 diabetes prevention program. This pilot project, taking place in St. Mary's Bay, Placentia, and Holyrood, aims to enhance diabetes risk factors over 12 months using Newtopia's personalized habit change platform. With diabetes costing Canada around $3.1 billion annually, the initiative is timely. Eastern Health seeks to improve healthcare services and outcomes through innovative solutions. The collaboration underscores Newtopia's focus on chronic disease prevention.
Newtopia Inc. (TSXV: NEWU), a tech-enabled habit change provider, announced participation in two investor conferences. The first is the Bloom Burton & Co. Healthcare Investor Conference on April 20-21, 2021, where management will present on April 21 at 3:30 pm ET, available via webcast on their website. The second event is the Stifel GMP & Stifel FirstEnergy Conference on April 21, with opportunities for investor meetings throughout the day. Newtopia focuses on disease prevention and offers tailored health programs leveraging genetic and behavioral insights.
Newtopia Inc. (NEWUF) reported robust financial growth in its FY 2020 results, with revenues rising by 87% to $11.4 million and gross profit increasing 179% to $5.5 million. Q4 2020 alone saw revenues jump 61% and gross profit soar 751%. Newtopia expanded its partnerships with Fortune 500 clients and launched a program targeting Medicare Advantage populations, potentially saving up to $1,700 per member. Looking forward, Newtopia expects steady revenue in H1 2021, followed by growth in H2, despite delays in product rollouts due to COVID-19.